Hirama H - Search Results

1

Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.

Sugimoto M, Kato T, Tohi Y, Shimizu Y, Matsumoto R, Inoue T, Takezawa Y, Masui K, Sasaki H, Hirama H, Saito S, Egawa S, Kamoto T, Teramukai S, Kojima S, Kikuchi T, Kakehi Y. Sugimoto M, et al. Among authors: hirama h. BMC Urol. 2022 Sep 14;22(1):151. doi: 10.1186/s12894-022-01096-3. BMC Urol. 2022. PMID: 36104667 Free PMC article.

2

[A case with hepatitis and interstitial pneumonitis caused by intravesical bacillus Calmette-Guérin (BCG) instillation].

Uetsuki H, Hirama H, Matsuoka Y, Miyauchi Y, Tsunemori H, Yamashita M, Inui M, Sugimoto M, Kakehi Y. Uetsuki H, et al. Among authors: hirama h. Nihon Hinyokika Gakkai Zasshi. 2011 Sep;102(5):691-5. doi: 10.5980/jpnjurol.102.691. Nihon Hinyokika Gakkai Zasshi. 2011. PMID: 22191278 Review. Japanese.

3

Cellular intermingling between adrenal gland and liver: an infrequent cause of incomplete resection at right adrenalectomy.

Sugimoto M, Hirama H, Hayashida Y, Shibuya S, Ueda N, Kakehi Y. Sugimoto M, et al. Among authors: hirama h. J Endourol. 2013 Jun;27(6):804-8. doi: 10.1089/end.2012.0708. Epub 2013 Apr 4. J Endourol. 2013. PMID: 23339404

4

The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort.

Hirama H, Sugimoto M, Ito K, Shiraishi T, Kakehi Y. Hirama H, et al. J Cancer Res Clin Oncol. 2014 Feb;140(2):257-63. doi: 10.1007/s00432-013-1566-2. Epub 2013 Dec 19. J Cancer Res Clin Oncol. 2014. PMID: 24352745 Free PMC article.

5

Case of vascular air embolism during holmium laser enucleation of the prostate.

Kato T, Sugimoto M, Matsuoka Y, Sakura Y, Hayashida Y, Hirama H, Tsunemori H, Ueda N, Uemura N, Miyawaki Y, Shirakami G, Kakehi Y. Kato T, et al. Among authors: hirama h. Int J Urol. 2015 Feb;22(2):227-9. doi: 10.1111/iju.12651. Epub 2014 Nov 13. Int J Urol. 2015. PMID: 25394391

6

Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN.

Sugimoto M, Hirama H, Yamaguchi A, Koga H, Hashine K, Ninomiya I, Shinohara N, Maruyama S, Egawa S, Sasaki H, Kakehi Y; PRIAS-JAPAN study group. Sugimoto M, et al. Among authors: hirama h. World J Urol. 2015 Jul;33(7):981-7. doi: 10.1007/s00345-014-1453-8. Epub 2014 Nov 27. World J Urol. 2015. PMID: 25428792

7

Retroperitoneal liposarcoma excreting insulin-like growth factor 2 that induced severe hypoglycemia.

Kato T, Sugimoto M, Yamashita M, Miyauchi Y, Hirama H, Tsunemori H, Ueda N, Imachi H, Shibuya S, Kushida Y, Kakehi Y. Kato T, et al. Among authors: hirama h. Int J Urol. 2017 Feb;24(2):162-165. doi: 10.1111/iju.13276. Epub 2016 Dec 24. Int J Urol. 2017. PMID: 28012446

8

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.

Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Bruinsma SM, et al. Nat Rev Urol. 2017 May;14(5):312-322. doi: 10.1038/nrurol.2017.26. Epub 2017 Mar 14. Nat Rev Urol. 2017. PMID: 28290462 Free article. Review.

9

The Effect of Steep Trendelenburg Positioning on Retinal Structure and Function during Robotic-Assisted Laparoscopic Procedures.

Hirooka K, Ukegawa K, Nitta E, Ueda N, Hayashida Y, Hirama H, Taoka R, Sakura Y, Yamasaki M, Tsunemori H, Sugimoto M, Kakehi Y. Hirooka K, et al. Among authors: hirama h. J Ophthalmol. 2018 Jun 13;2018:1027397. doi: 10.1155/2018/1027397. eCollection 2018. J Ophthalmol. 2018. PMID: 30009047 Free PMC article.

10

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.

Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, Bangma CH, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam VJ, Kattan MW; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium. Van Hemelrijck M, et al. Eur Urol. 2019 Mar;75(3):523-531. doi: 10.1016/j.eururo.2018.10.025. Epub 2018 Oct 29. Eur Urol. 2019. PMID: 30385049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters